Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    2024 RD Global Monitoring anti-TFPI RES
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Urothelial Carcinoma (UC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Health Services Research to Improve Management of mBC Patients Treated with Tucatinib
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Addressing Multiple Myeloma Gaps in Care for Patients in Latin America
    Release Date:
    Partner: International Myeloma Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Colombia, Mexico
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Management of Atopic Dermatitis / Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFP
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada, USA
    ADVANCE: Global Awards for Advancing Chronic Pain Research
    Release Date:
    Partner: Eli Lilly and Company
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 Era
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology United Kingdom
    New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)
    Release Date:
    Partner: Merck KGaA Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology France, Germany, Italy, Spain, USA, United Kingdom
    Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    PARP-inhibitor Combination Treatments in Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Remote Mentoring Programs in RCC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)
    Release Date:
    Partner: The Sharing Progress in Cancer Care (SPCC)
    Review Process: Expert Review Panel
    Quality Improvement Oncology All
    Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, USA
    NSCLC Oncogene Driver Considerations in Testing & Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Canada, USA
    Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology France, Germany